Paper Review Records
全部论文审稿周期
15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
115
天
[ 18 F]FDG PET/CT as an endpoint marker in drug interventional studies in atherosclerosis - a structured review
作者
Casper E. W. Gijsen; Felix M. Mottaghy; Ahmed Tawakol; Joachim E. Wildberger; Jan Bucerius展开收起
作者单位
1. Department of Radiology and Nuclear Medicine, Maastricht University Medical Center (MUMC⁺), Maastricht, the Netherlands; 2. Department of Nuclear Medicine, University Hospital RWTH Aachen, Aachen, Germany; 3. Cardiovascular Imaging Research Center, Massachusetts General Hospital, Boston, USA; 4. Department of Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, USA; 5. Cardiovascular Research Institute (CARIM), Maastricht University Medical Center (MUMC⁺), Maastricht, the Netherlands; 6. Division of Nuclear Medicine, Department of Radiology, Medical University of Graz, Graz, Austria展开收起
41
天
Biodistribution and dosimetry of the carbon-11 labelled PARP1-selective PET radiopharmaceutical [ 11 C]AZ14193391
作者
Anders Törnblom; Cecilia He; Martin Bolin; Antonios Tzortzakakis; Josefin Fernebro; Chunde Li; Susanne Fridsten; Renske Altena; Rimma Axelsson; Jonathan Siikanen; Cecilia Hindorf展开收起
作者单位
1. Department of Nuclear Medicine and Medical Physics Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; 2. Division of Molecular Medicine and Surgery (MMK), Karolinska Institutet, Stockholm, Sweden; 3. Division of Radiology Department for Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; 4. Centre for Psychiatry Research Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services Region, Stockholm, Sweden; 5. Department of Nuclear Medicine and Medical Physics Theranostics Trial Center, Karolinska University Hospital, Stockholm, Sweden; 6. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 7. Section of Gynecological Oncology, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Oncology, Södersjukhuset, Stockholm, Sweden; 9. Department of Clinical Science and Education, Karolinska Institutet Södersjukhuset, Stockholm, Sweden展开收起
132
天
Evaluation of the biodistribution of [ 99m Tc]Tc-PSMA-GCK01 SPECT/CT in a prospective, intraindividual comparison with [ 68 Ga]PSMA-11 PET/CT for phenotyping in mCRPC prior to PSMA-targeted radioligand therapy
作者
Emil Novruzov; Eduards Mamlins; Joseph Kabunda; Jens Cardinale; Milani Qebetu; Clemens Kratochwil; Anna Feisthauer; Stefan Martlbauer; Chimbabantu Alexis Kaoma; Sandile Sibiya; Tertia de Bruin; Sipho Mdanda; Mbongeni Shungube; Cindy Davis; Liani Smith; Yonwaba Mzizi; Kgomotso Mokoala; Honest Ndlovu; Keamogetswe Ramonaheng; Frederik L. Giesel; Mike M Sathekge展开收起
作者单位
1. Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany; 2. Centre for Integrated Oncology (CIO) Duesseldorf, CIO Aachen-Bonn-Cologne-Duesseldorf, Duesseldorf, Germany; 3. Department of Nuclear Medicine, University of Pretoria and Steve Biko Academic Hospital, Pretoria, South Africa; 4. Nuclear Medicine Research Infrastructure (NuMeRI), Pretoria, South Africa; 5. Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany展开收起
98
天
117
天
Early detection and localization of recurrent prostate cancer using \(^{18}\) F-DCFPyL PET/CT in patients with low and ultra-low PSA levels
作者
Ida Sonni; Alexandra Gulpe; Nicholas G. Nickols; Derace Schaffer; Louis Montagut; Gholam R. Berenji; Matthew B. Rettig展开收起
作者单位
1. Department of Radiological Sciences, University of California, Los Angeles, USA; 2. Department of Nuclear Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, USA; 3. EXINI Diagnostics AB, Lund, Sweden; 4. Department of Radiation Oncology, University of California, Los Angeles, USA; 5. Department of Radiation Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, USA; 6. Department of Urology, University of California, Los Angeles, USA; 7. Concord Academy, Concord, USA; 8. Department of Medicine, University of California, Los Angeles, USA; 9. Department of Medicine, Division of Hematology-Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, USA展开收起
162
天
Head-to-head comparison of 99m Tc-MIP-1404 CZT SPECT/CT and 68 Ga/PSMA-11 PET/CT for primary staging of high-risk prostate cancer: a phase II study
作者
Aws Saudi; Malin Ståhlgren; Prab Takhar; Pernilla Norberg; Martin Holmbom; Julia Dahl; Mostafa Afshar; Isidro Albert-García; Jon Forsberg; Marcus Ressner; Mathias Elgland; Veronica Sanchez-Rodriguez; Firas Aljabery; Miguel Ochoa-Figueroa展开收起
作者单位
1. Department of Clinical and Experimental Medicine, Division of Urology, Linköping University, Linköping, Sweden; 2. Department of Radiology in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 3. Curium Pharma (Nordics), Curium Pharma Finland OY, Helsinki, Finland; 4. Clinical Department of Medical Radiation Physics, Region Östergötland, Linköping, Sweden; 5. Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; 6. Department of Clinical Physiology in Linköping, Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden; 7. Department of Nuclear Medicine and Medical Radiation Physics, Karolinska University Hospital, Stockholm, Sweden; 8. Department of Radiology, Section for Molecular Imaging, Institution for Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden; 9. Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天